One IPO is currently scheduled for the week ahead, joined by Bill Ackman’s Pershing Square deals. Some smaller issuers may also join the calendar throughout the week. Pulmonary fibrosis biotech Avalyn Pharma (AVLN) is set to raise $201 million at a...read more
Four IPOs priced this past week, featuring nuclear tech, critical materials, real estate, and convenience stores. SMR developer X-Energy (XE) upsized and priced well above the range to raise $1.0 billion at a $9.5 billion market cap, the first advanced...read more
InterPrivate Investment Partners V, the fifth blank check company backed by InterPrivate targeting blockchain and digital assets, filed on Friday with the SEC to raise up to $175 million in an initial public offering. The company plans to raise $175 million...read more
US IPO Week Ahead: Lung disease biotech and Bill Ackman deals set to debut
One IPO is currently scheduled for the week ahead, joined by Bill Ackman’s Pershing Square deals. Some smaller issuers may also join the calendar throughout the week. Pulmonary fibrosis biotech Avalyn Pharma (AVLN) is set to raise $201 million at a...read more
US IPO Weekly Recap: Nuclear tech, critical materials, and more in a 4 IPO week
Four IPOs priced this past week, featuring nuclear tech, critical materials, real estate, and convenience stores. SMR developer X-Energy (XE) upsized and priced well above the range to raise $1.0 billion at a $9.5 billion market cap, the first advanced...read more
SPAC InterPrivate Investment Partners V files for a $175 million IPO, targeting blockchain and digital assets
InterPrivate Investment Partners V, the fifth blank check company backed by InterPrivate targeting blockchain and digital assets, filed on Friday with the SEC to raise up to $175 million in an initial public offering. The company plans to raise $175 million...read more